Company filings profile · CIK 0001385818
AYTU BIOPHARMA, INC — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for AYTU BIOPHARMA, INC (AYTU): 12 filings in the last 90 days vs 3 in the prior 90 (filing-velocity rising ↑ · 4×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 23, 2026. Source-linked, daily-refreshed.
Material 8-K events — AYTU BIOPHARMA, INC
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 22, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jun 25, 2026 | Termination of a Material Agreement | ↗ |
| May 13, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 2, 2026 | Entry into a Material Agreement; Results of Operations (earnings); Unregistered Sale of Securities; Item 3.03; Financial Statements and Exhibits | ↗ |
| Feb 3, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jan 20, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Dec 10, 2025 | Item 5.07 | ↗ |
| Nov 13, 2025 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Sep 23, 2025 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
Watch AYTU BIOPHARMA, INC automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 22, 2026 | 10-K | FORM 10-K | ↗ |
| Sep 22, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 30, 2026 | 4 | FORM 4 | ↗ |
| Jul 30, 2026 | 4 | FORM 4 | ↗ |
| Jul 30, 2026 | 4 | FORM 4 | ↗ |
| Jul 30, 2026 | 4 | FORM 4 | ↗ |
| Jul 30, 2026 | 4 | FORM 4 | ↗ |
| Jul 30, 2026 | 4 | FORM 4 | ↗ |
| Jul 30, 2026 | 4 | FORM 4 | ↗ |
| Jul 30, 2026 | 4 | FORM 4 | ↗ |
| Jun 25, 2026 | 8-K | Termination of a Material Agreement | ↗ |
| May 13, 2026 | 10-Q | FORM 10-Q | ↗ |
| May 13, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 2, 2026 | 8-K | Entry into a Material Agreement; Results of Operations (earnings); Unregistered Sale of Securities; Item 3.03; Financial Statements and Exhibits | ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 13, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 3, 2026 | 10-Q | FORM 10-Q | ↗ |
| Feb 3, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jan 20, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Dec 10, 2025 | 8-K | Item 5.07 | ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A | ↗ | |
| Nov 13, 2025 | 10-Q | FORM 10-Q | ↗ |
| Nov 13, 2025 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Nov 12, 2025 | SCHEDULE 13G/A | ↗ | |
| Oct 24, 2025 | ARS | ARS | ↗ |
| Oct 24, 2025 | DEFA14A | FORM DEFA14A | ↗ |
| Oct 24, 2025 | DEF 14A | FORM DEF 14A | ↗ |
| Oct 20, 2025 | 5 | ↗ | |
| Oct 7, 2025 | 4 | FORM 4 | ↗ |
| Oct 7, 2025 | 4 | FORM 4 | ↗ |
| Oct 7, 2025 | 4 | FORM 4 | ↗ |
| Oct 7, 2025 | 4 | FORM 4 | ↗ |
| Oct 7, 2025 | 4 | FORM 4 | ↗ |
| Oct 7, 2025 | 4 | FORM 4 | ↗ |
| Oct 7, 2025 | 4 | FORM 4 | ↗ |
| Oct 7, 2025 | 4 | FORM 4 | ↗ |
| Sep 23, 2025 | S-8 | FORM S-8 | ↗ |
| Sep 23, 2025 | 10-K | FORM 10-K | ↗ |
| Sep 23, 2025 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |